PRECISIS GmbH

PRECISIS GmbH is a medical technology company based in Heidelberg, Germany. The company specializes in developing minimally invasive neurostimulation therapies aimed at treating neurological disorders. Its mission is to enhance the lives of patients with brain disorders through innovative bioelectronic technology.

The flagship product, EASEE®, is a groundbreaking brain pacemaker designed for patients with drug-resistant focal epilepsy. It is implanted beneath the scalp without penetrating brain tissue, significantly reducing surgical risks and recovery times. EASEE® has shown promising clinical results, with over half of the patients experiencing reduced seizure frequency. The product is CE-certified and available in parts of Europe, with plans for U.S. regulatory approval.

PRECISIS utilizes AI-based learning models to personalize therapy for patients, with future applications planned for conditions such as depression, Parkinson's disease, chronic pain, and stroke. The company is committed to international growth and collaborates with academic and clinical partners to support its innovative product development.